Last updated on January 2019

Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid


Brief description of study

This study is a placebo-controlled, randomized, double-blind, multicenter, parallel-group comparison study in primary biliary cholangitis participants inadequately responding to ursodeoxycholic acid.

Clinical Study Identifier: NCT03092765

Contact Investigators or Research Sites near you

Start Over

Public Relations Group

EA Pharma trial site #1
Sapporo, Japan

Public Relations Group

EA Pharma trial site #2
Sapporo, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.